LifeSciVC

FEBRUARY 27, 2024

By Ivana Magovčević-Liebisch, CEO of Vigil Neuroscience, as part of the From The Trenches feature of LifeSciVC Patients and their care partners are at the center of our work in the life sciences industry – but at what point during the drug development process should companies start to engage these key stakeholders?

Drug Development 60

Drug Development Disease Drugs Treatment 60

Alta Sciences

APRIL 17, 2024

Five Promising Treatment Areas in Early-Phase Drug Development in 2024 aasimakopoulos Wed, 04/17/2024 - 15:52 Early-phase drug development is an ever-changing landscape, as emerging science leads to new promising areas of research for the treatment of human health issues.

Drug Development 52

Drug Development Treatment FDA Approval Therapies 52

Alta Sciences

JUNE 9, 2023

Accelerating Global Drug Development Timelines With Ethnobridging rmaloney Mon, 06/12/2023 - 16:07 HTML Safe Strategy to Save Time and Money Avoid repeating Phase I studies for drugs intended for the Asian market. Download your copy today. In this complimentary webinar , Mel B. Watch the webinar.

Drug Development 40

Drug Development Clinical Trials Biosimilars Pharmacokinetics 40

The Pharma Data

SEPTEMBER 15, 2020

Find out solutions to mitigate the impact from clinical supply chain risk and discover how to improve dynamic drug supply forecasting strategies. Join this webinar to learn how supply forecasting and interactive response technology can help biotech companies improve supply planning and distribution while reducing cost and risk.

Clinical Supply 52

Clinical Supply Clinical Trials Doctors Clinical Development 52

Alta Sciences

JANUARY 22, 2024

Get a Head Start On Your 2024 Preclinical Drug Development Program blussier Mon, 01/22/2024 - 15:18 HTML EXPERTISE Matters. With four strategically placed preclinical research facilities throughout North America, Altasciences can get your CTA/IND-enabling studies underway in just 8 weeks!

Drug Development 40

Drug Development Clinical Trials Drugs Trials 40

Fierce BioTech

JANUARY 12, 2024

Developing and Manufacturing Minitablets to Extend Drug Lifecycle pesurya Fri, 01/12/2024 - 12:38 Wed, 02/28/2024 - 11:00 Resource Type Webinar Robert Strickley, PhD Valjon Demiri, MSc Duration 60 Minutes Oral minitablets can offer several advantages in pharmaceutical applications, making them a valuable option in drug delivery.

Drugs 52

Drugs Packaging Compliance Drug Development 52

Cytel

APRIL 3, 2024

Thank you to Charlotta Gauffin, Chief Scientific Officer at Dicot, for joining us for our recent webinar, “The Road to First-in-Human Trials: Insights from a Real-World Example.” Thoughtfully and carefully planned nonclinical studies help pave a smooth path toward first-in-human Phase 1 clinical trials.

Clinical Trials 59

Clinical Trials Drugs Trials Drug Development 59

Fierce BioTech

JULY 17, 2023

Best practices for capturing reproducible and accurate in vivo data to reduce failure in clinical trials – the most expensive phase of drug development. Discussion will include: Current in vivo study management practices and processes. How did we get here?

Clinical Trials 88

Clinical Trials Drug Development Research Trials 88

Conversations in Drug Development Trends

OCTOBER 26, 2022

Having worked in psychedelic research since the advent of industry-sponsored trials, Worldwide Clinical Trials has amassed the expertise needed to execute these studies successfully, recently sharing insights in a webinar titled “ Demystifying Complex Operations in Psychedelic Research ,” available on-demand now. Check out the full webinar !

Trials 97

Trials Clinical Trials Licensing Licensing 97

Conversations in Drug Development Trends

JUNE 13, 2024

At Worldwide, Matt Cooper and Jim Eamma , our Executive Directors, Therapeutic Strategy Leads in Oncology, shed light on the intricacies of modern oncology trials in their recent webinar, “ Navigating the Landscape of Complex & Adaptive Oncology Trials.” How Does Project Optimus Impact Your Study’s Operations?

Trials 52

Trials Clinical Trials Drug Development Clinical Development 52

Fierce BioTech

SEPTEMBER 13, 2024

Highlights From the Final ICH Drug Interactions Guideline pesurya Fri, 09/13/2024 - 11:39 Thu, 10/31/2024 - 11:00 Resource Type Webinar Brian Ogilvie Graham Dyck Duration 60 Minutes The ICH M12 Guideline was finalized on May 21st, 2024, after extensive review of industry and other comments.

Drugs 52

Drugs FDA Drug Development 52

Fierce BioTech

MAY 1, 2024

BioDuro-Sundia has developed a comprehensive synthetic peptide discovery platform to help client in their drug discovery efforts. png Listing Introduction Join us on Monday, June 19, 2024 for one hour all about oral cyclic peptide drug development. Click here to login. Listing Image BioDuro_ListingLogo_250x190.png

Drugs 52

Drugs Drug Development 52

Alta Sciences

JULY 22, 2024

Recently, we have seen increasing numbers of complex FIH studies in CNS-active drugs to gather comprehensive data with a wider range of doses as early as possible. jpg Tags Clinical Trials Weight 1

Trials 52

Trials Clinical Trials Clinical Development Clinical Research 52

Conversations in Drug Development Trends

FEBRUARY 22, 2023

Our rare disease team at Worldwide will be hosting a panel discussion webinar with patient advocates active in Rare Disease Day events to synthesize the most salient conversations taking place. See their conversation below and register for the webinar to hear more from these advocates!

Disease 52

Disease Clinical Trials Trials Treatment 52

Fierce BioTech

APRIL 4, 2024

Discover how leading organizations leverage AI to revolutionize operations and expedite drug development, ensuring faster access to life-saving treatments. Join our webinar: AI Advancements in Life Sciences: Accelerating Innovation. Listing Image Appian-LogoListing-9142023.png Register now!

Science 52

Science Compliance Drug Development Treatment 52

Fierce BioTech

APRIL 10, 2024

Redefining Antibody Specificity Profiling for IND swheeler Wed, 04/10/2024 - 17:56 Thu, 06/06/2024 - 11:00 Resource Type Webinar Kris Raghavan, PhD Fernanda I. Staquicini, PhD Duration 60 minutes Assessment of antibody off-target reactivity is a regulatory requirement for clinical development. So, what are the alternatives?

Clinical Development 52

Clinical Development FDA Drug Development Drugs 52

Fierce BioTech

OCTOBER 26, 2023

pesurya Thu, 10/26/2023 - 14:05 Tue, 12/05/2023 - 11:00 Resource Type Webinar Julie Bullock, PharmD Krithika Shetty, PhD Blaire Osborn, Ph.D. Eva Gil Berglund, PhD Justin Hay, PhD Paola Coppola, MSc Duration 60 Minutes Clinical pharmacology information comprises more than 50% of a drug label. Click here to login.

Clinical Pharmacology 52

Clinical Pharmacology Drug Development Regulations FDA 52

Fierce BioTech

MARCH 5, 2024

Genetic data combined with linked longitudinal clinical data, including full labs & patient vitals/demographics, has been shown to optimize target discovery and address the challenges of 'precision’ medicine development. Click here to login.

Drug Development 52

Drug Development Disease Research Drugs 52

Fierce BioTech

MARCH 12, 2024

For biopharma and biotech companies, FSP partnerships have emerged as a pivotal strategy for accessing the complementary expertise and resource flexibility they need to meet their timelines, and innovative providers are implementing new, globalized FSP strategies to keep their clients ahead of the curve.

Clinical Research 52

Clinical Research Drug Development Trials Research 52

Elrig

APRIL 29, 2024

Webinar | Ai At The Frontier: Empowering Early Career Professionals In Drug Discovery WEBINAR – ARE YOU CURIOUS ABOUT THE CUTTING-EDGE INTERSECTION OF ARTIFICIAL INTELLIGENCE AND DRUG DISCOVERY? Are you curious about the cutting-edge intersection of Artificial Intelligence and Drug Discovery?

Bioinformatics 59

Bioinformatics Drugs Molecular Biology Cell Based Assays 59

Fierce BioTech

MAY 1, 2024

Join us on Monday, June 19, 2024 for one hour all about oral cyclic peptide drug development. With “specialized for peptide” drug metabolism and pharmacokinetics (DMPK) and biological evaluation, we’re able to solve certain synthesis issues found across different cyclic peptides, complexes peptides and mimetic peptides.

Pharmacokinetics 52

Pharmacokinetics Drug Development Drugs 52

Fierce BioTech

SEPTEMBER 6, 2023

Organofluorine Chem in Pharma Intermediates & APIs swheeler Wed, 09/06/2023 - 12:54 Wed, 10/18/2023 - 11:00 Resource Type Webinar Dr. Yuanqiang Li Dr. Pete Newsome Peter Halkjaer-Knudsen Duration 60 minutes Topics Covered: Introduction to Organofluorine Chemistry and its significance in pharmaceuticals. Click here to login.

Pharmaceuticals 52

Pharmaceuticals Drug Development Drugs Research 52

PPD

SEPTEMBER 16, 2024

The convergence of real-world data (RWD), technology and artificial intelligence (AI) is playing a vital role in accelerating drug development. In a recent panel discussion at DIA Global , our experts explored how these elements are reshaping clinical research and drug discovery.

Clinical Development 52

Clinical Development Clinical Trials Clinical Research Trials 52

PPD

OCTOBER 16, 2023

Tokenization can accelerate innovation in clinical trials and drug development. Once in the data lake, tokenized data can be linked using a special linking software based on the data usage agreements to create longitudinal patient data. This enables deeper and more meaningful real-world insights on clinical study data.

Clinical Trials 98

Clinical Trials Trials Research Therapies 98

Alta Sciences

AUGUST 7, 2024

blussier Wed, 08/07/2024 - 19:51 HTML Timing is Everything Early collaboration with an experienced CDMO is crucial in drug development to mitigate manufacturing risks and ensure the efficient formulation of your API for preclinical and clinical testing. Contact us today to discuss the next stage of your drug development journey.

Clinical Trials 40

Clinical Trials Compliance Drug Development Trials 40

Conversations in Drug Development Trends

AUGUST 10, 2023

As psychedelic drugs move into clinical trials, we have an opportunity and responsibility to conduct ethically rigorous studies that encompass the experiences of a diverse and representative population. Worldwide has already made significant investments in diversity, equity, and inclusion, and we continually work to refine these efforts.

Science 98

Science Clinical Trials Trials Clinical Research 98

The Pharma Data

SEPTEMBER 9, 2020

We respect your privacy, by clicking “Download Your Copy” you will receive our e-newsletter, including information on Podcasts, Webinars, event discounts, online learning opportunities and agree to our User Agreement. Develop a fully automated environment to significantly boost research efforts.

Production 52

Production Laboratories Compliance Government 52

Fierce BioTech

JULY 27, 2023

Process Chemistry Unleashed: A 'Fit-for-Purpose' Approach to Accelerate IND Filing pesurya Thu, 07/27/2023 - 11:27 Tue, 09/05/2023 - 10:00 Resource Type Webinar Qixuan Lu Duration 60 Minutes Process chemistry plays a pivotal role in various stages of the pharmaceutical R&D cycle. Listing Image BioDuro_LogoListingNew_6142023.png

Process Chemistry 52

Process Chemistry Compliance FDA Drug Development 52

Alta Sciences

SEPTEMBER 5, 2024

These findings validate this animal model as a valuable tool for regulatory pharmacology and drug safety, enhancing cross-species assessments and improving understanding of drug metabolism and potential toxicities. Read it now! ​​​​​​ WHITE PAPER Questions?

Drug Development 40

Drug Development Drugs Research 40

Alta Sciences

JANUARY 24, 2024

Discover the Power of Driving Simulations for CNS Side-Effect Analysis blussier Wed, 01/24/2024 - 18:25 HTML Start Your Driving Trial Quickly—Simulators On-Site Driving simulator studies are a safe, efficient, and effective alternative to on-the-road driving trials for CNS-active drugs. jpg Tags Clinical Trials Weight 1

Clinical Trials 40

Clinical Trials Trials FDA Drug Development 40

Alta Sciences

MARCH 21, 2024

Watch Now The Altascientist: Central Nervous System Early-phase development of CNS-acting drugs is a complex, challenging undertaking. In this article, we provide a detailed overview of the multiple facets you need to consider during the planning and conduct of your CNS-active drug development.

Clinical Trials 40

Clinical Trials Trials Drug Development FDA 40

The ChEMBL-og

SEPTEMBER 17, 2020

During drug development, active pharmaceutical ingredients are often formulated as salts to provide the final pharmaceutical product. From the ChEMBL interface The ‘Drugs’ and ‘Mechanism’ views contain only parent molecules and so mechanisms are automatically mapped to the parent form.

Pharmaceuticals 52

Pharmaceuticals Drug Development Production Drugs 52

Alta Sciences

NOVEMBER 20, 2024

EXPLORE Related resources you may be interested in: eBook: Nonclinical Studies in Cell and Gene Therapy Webinar: Best Practices to Reduce Animal Use in Toxicology Studies Webpage: The Use of Miniature Swine in Preclinical Studies Image alta-blog_4_2.jpg jpg Tags Preclinical Research Weight 1

Therapies 40

Therapies Drug Development Research Drugs 40

Alta Sciences

JULY 5, 2023

A Game-Changer for Poorly Soluble APIs asikora Wed, 07/05/2023 - 21:21 HTML Fact : Over 70% of active pharmaceutical ingredients (APIs) entering the drug development pipeline are poorly water-soluble and thus, insufficiently bioavailable.

Drug Development 40

Drug Development Pharmaceuticals Drugs 40

Alta Sciences

AUGUST 15, 2023

Related resources that may interest you: Webinar : Advantages of Terminal Sterilization Over Aseptic Manufacturing Scientific Journal : Terminal Sterilization of Pharmaceutical products Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining (..)

Packaging 40

Packaging FDA Production Drug Development 40

Fierce BioTech

OCTOBER 26, 2023

Separating the Science from the Fiction: Bringing the Lab of the Future to In Vivo Studies swheeler Thu, 10/26/2023 - 12:09 Thu, 12/07/2023 - 14:00 Resource Type Webinar Julie Morrison Ian Levine Jason M.

Science 52

Science Drug Development Research Drugs 52

Alta Sciences

JUNE 2, 2023

Altasciences can help you compile the key information necessary to approve your application request, including: Animal pharmacology and toxicology studies to assess safety; Manufacturing processes to ensure consistent batches of the study drug; Clinical protocols and investigator information to assess tolerance and risk.

Small Molecule 40

Small Molecule Drug Development Research Drugs 40